IMDX
Insight Molecular Diagnostics
IMDX
IMDX
37 hedge funds and large institutions have $33.3M invested in Insight Molecular Diagnostics in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
10% less funds holding
Funds holding: 41 → 37 (-4)
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Holders
37
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$2.83M | |
| 2 | +$131K | |
| 3 | +$19.4K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$16.7K |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
+$8.06K |
Top Sellers
| 1 | -$218K | |
| 2 | -$51K | |
| 3 | -$40.5K | |
| 4 |
FM
Family Management
New York
|
-$10.6K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$6.81K |